InsiderClue
Insiders · Profile

Rovaldi Christopher

Chief Operating Officer at Keros Therapeutics. Filing since 1 Apr 2022. CIK 0001706040

Company
Date
Role
Action
Shares
Amount
Of holding
KROS Keros Therapeutics, Inc.
6 Apr 2022
Chief Operating Officer
Sold, plan not stated
1,728
$112.32K
100%
KROS Keros Therapeutics, Inc.
1 Apr 2022
Chief Operating Officer
Sold, plan not stated
864
$49.68K
100%
2 decisions on file.